Back
Altisource Portfolio Solutions SA Vs. Nektar Therapeutics Industry Stock Comparison
Sell
27
ASPS
Altisource Portfolio Solutions SA
Last Price:
$11.36
Seasonality Move:
-2.61%
Sell
50
NKTR
Nektar Therapeutics
Last Price:
$22.48
Seasonality Move:
-1.52%
Sell
27
Altisource Portfolio Solutions SA (ASPS)
is a Sell
Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?
-
The current Altisource Portfolio Solutions SA [ASPS] share price is $11.23. The Score for ASPS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ASPS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $22.56. The Score for NKTR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASPS Stock Price Chart
What is Altisource Portfolio Solutions SA's stock price today?
-
The Altisource Portfolio Solutions SA share price today is $11.23The current trend is moderately bearish and ASPS is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $22.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
ASPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 50.4 | Buy |
| Chaikin Money Flow: | -3688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.23 - 13.47) | Sell |
| Bollinger Bands (100): | (5.83 - 10.77) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.96 | Buy |
| Relative Strength Index (14 RSI): | 50.77 | Buy |
| Chaikin Money Flow: | -259124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.91 - 25.21) | Sell |
| Bollinger Bands (100): | (7.9 - 21.3) | Buy |
ASPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.81 | Buy |
| 20-day SMA: | 12.29 | Sell |
| 50-day SMA: | 9.9 | Buy |
| 200-day SMA: | 7.47 | Buy |
| 8-day EMA: | 11.21 | Buy |
| 20-day EMA: | 11.36 | Sell |
| 50-day EMA: | 10.31 | Buy |
| 200-day EMA: | 9.29 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.01 | Sell |
| 20-day SMA: | 24.02 | Sell |
| 50-day SMA: | 18.7 | Buy |
| 200-day SMA: | 14.97 | Buy |
| 8-day EMA: | 17.63 | Buy |
| 20-day EMA: | 10.2 | Buy |
| 50-day EMA: | 4.82 | Buy |
| 200-day EMA: | 1.31 | Buy |
Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
Altisource Portfolio Solutions SA Technical Analysis
| Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||